Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model

被引:24
|
作者
Brackett, Charles D. [1 ,2 ,3 ]
Duncan, Matthew [3 ,4 ]
Wagner, Joanne Fadale [4 ]
Fineberg, Laura [2 ]
Kraft, Sally [2 ,3 ]
机构
[1] Dartmouth Hitchcock, Sect Gen Internal Med, Lebanon, NH USA
[2] Dartmouth Hitchcock, Populat Hlth, Lebanon, NH USA
[3] Dartmouth Coll, Geisel Sch Med Dartmouth, Hanover, NH 03755 USA
[4] Dartmouth Hitchcock, Dept Psychiat, Lebanon, NH USA
关键词
Buprenorphine; collaborative care model; opioid use disorder; medications for addiction treatment (MAT); behavioral health integration; BUPRENORPHINE; DEPRESSION; PHYSICIANS;
D O I
10.1080/08897077.2021.1932698
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Treatment of opioid use disorder (OUD) is highly effective, but access is limited and care is often fragmented. Treatment in primary care can improve access to treatment and address psychiatric and physical co-morbidities in a holistic, efficient, and non-stigmatizing way. The Collaborative Care Model (CCM) of behavioral health integration into primary care has been widely disseminated and shown to improve outcomes and lower costs when studied for depression, but its use in treating substance use disorders has not been well documented. Methods: We used a mixed-methods approach to examine the impact of implementing multidisciplinary treatment of OUD in our health system's five primary care clinics using the framework of the CCM, with care shared between the primary care clinician (PCP), behavioral health clinician, and medical assistant. The implementation included staff education, creation of electronic health record tools, and implementation support, and was evaluated using data from the electronic health record, the medical staff office, and a clinician survey. Results: Over the last 2 years of implementation, the number of waivered providers increased from 11 to 35, providers prescribing for 5 or more patients increased from 2 to 18, and patients initiated on buprenorphine increased from 4/month to 18/month. 180-day treatment retention was 53%, and 81% of patients had consistently negative urine drug testing. Psychiatric and medical comorbidities were common, 70 and 44%, respectively. Although PCPs who prescribed buprenorphine found working in this model enjoyable and effective, the majority of non-waivered PCPs remained reluctant to participate. Conclusions: In our experience, treatment of OUD in primary care utilizing the CCM effectively addresses OUD and commonly comorbid anxiety and depression, and leads to an expansion of treatment. Successful implementation of OUD treatment requires addressing negative attitudes and perceptions.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 50 条
  • [31] Primary Care Patients With Opioid Use Disorder Symptoms: Engagement in Treatment With Medication
    Simon, Claire
    Matson, Theresa
    Oliver, Malia
    Hallgren, Kevin
    Weiss, Roger
    Bradley, Katharine
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267
  • [32] Tier-Based Treatment for Opioid Use Disorder in the Primary Care Setting
    Angier, Heather
    Fleishman, Joan
    Gordon, Leah
    Cohen, Deborah J.
    Cantone, Rebecca E.
    Bailey, Steffani R.
    FAMILIES SYSTEMS & HEALTH, 2021, 39 (02) : 345 - 350
  • [33] Increasing Capacity for Treatment of Opioid Use Disorder in Rural Primary Care Practices
    Zittleman, Linda
    Curcija, Kristen
    Nease, Donald E., Jr.
    Fisher, Mary
    Dickinson, L. Miriam
    Thomas, John F.
    Espinoza, Ashley
    Sutter, Christin
    Ancona, Jennifer
    Holtrop, Jodi Summers
    Westfall, John M.
    ANNALS OF FAMILY MEDICINE, 2022, 20 (01) : 18 - 23
  • [34] Medication treatment for opioid use disorder among rural primary care patients
    Hser, Yih-Ing
    Zhu, Yuhui
    Baldwin, Laura-Mae
    Mooney, Larissa J.
    Saxon, Andrew J.
    JOURNAL OF RURAL HEALTH, 2024, 40 (01): : 195 - 199
  • [35] PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment
    Campbell, Cynthia I.
    Saxon, Andrew J.
    Boudreau, Denise M.
    Wartko, Paige D.
    Bobb, Jennifer F.
    Lee, Amy K.
    Matthews, Abigail G.
    McCormack, Jennifer
    Liu, David S.
    Addis, Megan
    Altschuler, Andrea
    Samet, Jeffrey H.
    LaBelle, Colleen T.
    Arnsten, Julia
    Caldeiro, Ryan M.
    Borst, Douglas T.
    Stotts, Angela L.
    Braciszewski, Jordan M.
    Szapocznik, Jose
    Bart, Gavin
    Schwartz, Robert P.
    McNeely, Jennifer
    Liebschutz, Jane M.
    Tsui, Judith I.
    Merrill, Joseph O.
    Glass, Joseph E.
    Lapham, Gwen T.
    Murphy, Sean M.
    Weinstein, Zoe M.
    Yarborough, Bobbi Jo H.
    Bradley, Katharine A.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [36] PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment
    Cynthia I. Campbell
    Andrew J. Saxon
    Denise M. Boudreau
    Paige D. Wartko
    Jennifer F. Bobb
    Amy K. Lee
    Abigail G. Matthews
    Jennifer McCormack
    David S. Liu
    Megan Addis
    Andrea Altschuler
    Jeffrey H. Samet
    Colleen T. LaBelle
    Julia Arnsten
    Ryan M. Caldeiro
    Douglas T. Borst
    Angela L. Stotts
    Jordan M. Braciszewski
    José Szapocznik
    Gavin Bart
    Robert P. Schwartz
    Jennifer McNeely
    Jane M. Liebschutz
    Judith I. Tsui
    Joseph O. Merrill
    Joseph E. Glass
    Gwen T. Lapham
    Sean M. Murphy
    Zoe M. Weinstein
    Bobbi Jo H. Yarborough
    Katharine A. Bradley
    Addiction Science & Clinical Practice, 16
  • [37] Adapting Psychotherapy in Collaborative Care for Treating Opioid Use Disorder and Co-Occurring Psychiatric Conditions in Primary Care
    French, Rachel
    Worley, Julie
    Lowenstein, Margaret
    Bogner, Hillary R.
    Calderbank, Tara
    DePhilippis, Dominick
    Forrest, Andrew
    Gibbons, Mary Beth Connolly
    Harris, Rebecca Arden
    Heywood, Saida
    Kampman, Kyle
    Mandell, David S.
    McKay, James R.
    Newman, Schyler Tristen
    Oslin, David W.
    Wadden, Steven
    Wolk, Courtney Benjamin
    FAMILIES SYSTEMS & HEALTH, 2023, : 377 - 388
  • [38] Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
    Cantone, Rebecca E.
    Garvey, Brian
    O'Neill, Allison
    Fleishman, Joan
    Cohen, Deborah
    Muench, John
    Bailey, Steffani R.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (05) : 724 - 731
  • [39] The primary care behavioral health model (PCBH) and Medication for opioid use disorder (MOUD): Integrated models for primary care
    Zerden, Lisa de Saxe
    Cooper, Zachary
    Sanii, Hannah
    SOCIAL WORK IN MENTAL HEALTH, 2022, 20 (02) : 149 - 158
  • [40] The primary care behavioral health model (PCBH) and medication for opioid use disorder (MOUD): integrated models for primary care
    Zerden, Lisa de Saxe
    Cooper, Zachary
    Sanii, Hannah
    SOCIAL WORK IN MENTAL HEALTH, 2021, 19 (02) : 186 - 195